A brand name alone does not tell you whether Extra-D Time is a tadalafil product, a tadalafil-dapoxetine combination, or another formulation. By checking the approved composition, safety profile, batch records, label, and commercial terms in the right order, you can decide whether the product belongs in your portfolio and how to quote it responsibly.
Key takeaways
- Confirm active ingredients and strength from the current carton and product licence.
- Match warnings and contraindications to the verified composition.
- Request the batch CoA, licence copy, and complete procurement terms.
- Check label details and channel restrictions before promoting the brand.
Confirm the composition before you quote or promote the product
Extra-D Time is a brand name, not a composition. Before you quote extra d time tablets pcd pharma in chandigarh, confirm the exact active ingredients and strength per tablet from the current carton, manufacturer’s specification, product licence, and batch-specific Certificate of Analysis (CoA).
Do not infer the formula from an old listing or a similar brand.
1. Record every declared ingredient, including sildenafil, tadalafil, vardenafil, dapoxetine, vitamins, herbal extracts, or any combination. A tadalafil-plus-dapoxetine tablet is not interchangeable with tadalafil alone.
2. Match the carton to the approved product permission and manufacturing licence. The name, dosage form, tablet strength, pack size, strip configuration, manufacturer, batch number, and licence details must agree across the documents.
3. Request stability data, stated storage temperature, shelf life, and the batch release record. Without these, you cannot responsibly promise a remaining shelf life or set handling instructions for distributors.
4. Confirm the approved indication and prescription marking, including Schedule H, Schedule H1, or another applicable classification. Dapoxetine also requires an alcohol warning because combining it with alcohol can increase dizziness, drowsiness, impaired reflexes, and syncope.
Treat missing or conflicting documents as a stop sign, not a sales opportunity. A brochure alone cannot define Extra-D Time as an erectile-dysfunction, premature-ejaculation, stamina, or general-wellness product. Quote only the composition and claim supported by the current regulatory file.
Match the indication, contraindications, and warnings to the actual ingredients
Do not classify the tablet from the brand name or sales phrase. For extra d time tablets for distributors, match the approved indication to the current carton, batch-specific Certificate of Analysis, product licence, manufacturer’s specification and approved product permission. If these records do not agree, pause the quotation.
- Tadalafil, sildenafil or vardenafil indicates a PDE5-inhibitor erectile dysfunction product, not a premature-ejaculation treatment. Do not treat these ingredients as interchangeable; their strengths and warnings differ.
- Dapoxetine indicates a short-acting SSRI intended for premature ejaculation when that indication is approved. A tadalafil-plus-dapoxetine tablet combines two indications and is not equivalent to tadalafil alone.
- Vitamins, minerals or herbal extracts support only the claim authorised for that formulation. Do not present a general wellness or stamina claim as treatment for erectile dysfunction or premature ejaculation.
Before listing or promoting it, screen the buyer’s counselling material for these safety points:
- Ask about nitrates or “poppers” before discussing any PDE5 inhibitor; concurrent use can cause a dangerous fall in blood pressure. Review cardiovascular disease and interacting medicines.
- For dapoxetine, flag monoamine-oxidase inhibitors, thioridazine, SSRIs, SNRIs, tricyclic antidepressants and other serotonergic medicines.
- Warn against alcohol with dapoxetine because dizziness, drowsiness, impaired reflexes and fainting can increase. Include syncope and orthostatic-hypotension warnings, and retain the applicable Schedule H or H1 prescription marking.
Set dosing and storage instructions only from approved product information
Do not train a sales representative to say “take one tablet before sex” until the approved product information identifies the ingredients, strength, dosage form, and indication. Record the exact wording from the product permission, package insert, and licensed label; a brochure cannot replace them.
| Detail | What the product file must record | What staff may say |
|---|---|---|
| Administration | Dose, timing, maximum frequency, food instructions, and missed or delayed-dose advice | Repeat only the approved instructions |
| Pack | Tablet strength, dosage form, tablets per carton and strip, batch number, expiry, and Schedule H, H1, or other prescription marking | Quote the exact pack, not “one strip” |
| Storage | Labelled temperature range and protection from heat, moisture, or light | Give the storage wording exactly |
| Shelf life | Total approved shelf life, expiry format, and minimum remaining life at dispatch | Do not promise stock beyond the recorded expiry |
If the product contains 30 mg dapoxetine, European product information describes administration approximately 1–3 hours before sexual activity and no more than once in 24 hours. Consider 60 mg only after assessing response and tolerability; confirm that strength against the Indian product licence before using this instruction.
Keep the approved label, package insert, manufacturing licence, product permission, batch CoA, stability data, and packing record together. If any document conflicts with the carton, pause training and customer counselling until the discrepancy is resolved.
Compare the complete procurement file, not just the price per strip
A lower strip price does not make Extra-D Time the better buy. Compare the full file against each alternative, because a missing CoA, short shelf life, or unclear replacement term can cost more than the initial discount.
| Comparison point | Extra-D Time file | Other PCD pharma products in Chandigarh | Decision |
|---|---|---|---|
| Composition | Active ingredients, strength per tablet, dosage form, and approved indication on the current carton and product permission | Match the same details from the current label and licence | Reject any product where the label and permission differ |
| Batch control | Batch-specific CoA, release record, manufacturing licence, batch number, and expiry | Request the same documents for every proposed batch | Do not rely on a brochure |
| Commercial terms | Strip count, pack size, MOQ, dispatch shelf life, freight, and payment terms | Compare identical units, not only price per strip | Calculate usable cost per saleable tablet |
| After-sales protection | Written replacement for transit damage, leakage, short expiry, or shortage | Confirm the supplier’s response time and credit method | Record the term before ordering |
| Traceability | Invoice and label must carry matching batch and licence details | Verify the same trail | Hold stock with mismatches |
Do not quote these extra d time tablets for distributors as interchangeable with tadalafil-only products if the verified composition contains tadalafil plus dapoxetine. Tadalafil addresses erectile dysfunction; dapoxetine addresses premature ejaculation, and alcohol warnings affect counselling because dizziness, impaired reflexes, and syncope can increase. Compare the approved indication, not the brand name.
Check the manufacturer, label, and channel terms before adding the brand
A low price does not make an Extra-D Time arrangement reliable. Reject the deal if the supplier cannot connect the proposed pack to a licensed manufacturer, a released batch, and a written territory agreement.
1. Ask for the manufacturer’s drug manufacturing licence, product permission, current specification, and the exact carton artwork. Match the declared active ingredients and strength per tablet with those documents; do not rely on a brochure or a reused brand name.
2. Request the batch-specific Certificate of Analysis, stability information, packing details, expiry date, and release record. Confirm that the batch number, manufacturing licence details, product name, and strength match across the carton, strip, invoice, and CoA.
3. Check whether the label carries Schedule H, H1, or another applicable prescription warning. If dapoxetine is present, reject promotional language suggesting unrestricted alcohol use because alcohol can increase dizziness, impaired reflexes, drowsiness, and fainting.
4. Put minimum order quantity, dispatch shelf life, replacement for transit damage or short expiry, payment terms, territory limits, and monopoly conditions in writing. Confirm who owns returns and unsold stock.
5. Verify the supplier’s drug-sale licence, invoice trail, tamper-evident or serialised packaging where supplied, and batch confirmation from the manufacturer. Use the same checks for Extra-D Time tablets PCD pharma in Chandigarh and for other PCD pharma products in Chandigarh.
For a listing such as Extra-D Time tablets Macrozz Healthcare, Macrozz Healthcare should be assessed through this evidence, not the brand name alone.
Related product
 | Extra-D Time Tablets by Macrozz Healthcare are specially formulated to support men’s health and performance. View product → |
Frequently asked questions
What should Chandigarh PCD buyers confirm before quoting Extra D Time tablets?
Confirm the active ingredients, strength per tablet, current carton details, manufacturer’s specification, product licence, and batch-specific Certificate of Analysis.
Why must buyers match warnings to the actual Extra D Time composition?
Extra D Time is a brand name rather than a composition. Indications, contraindications, warnings, and dosing depend on the verified active ingredients and strengths.
Which documents should distributors request before procurement?
Request the product licence copy, manufacturer’s specification, batch-specific CoA, current label or carton artwork, and written channel terms.
What should buyers check before adding Extra D Time to a PCD portfolio?
Check the manufacturer identity, active ingredients, strength, batch details, label compliance, storage instructions, and agreed PCD, monopoly, or distribution terms.
Keywords
